M. H. Frick
Helsinki University Hospital · 127 works · 10,919 citations · h-index 37
Top works
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
- Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study
- Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.
- Measurement of the Angina Threshold Using Atrial Pacing: A New Technique for the Study of Angina Pectoris
- Coronary Heart Disease Incidence in NIDDM Patients In The Helsinki Heart Study
- Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants
- Prevention of progression of coronary atherosclerosis by treatment of hyperlipidaemia: a seven year prospective angiographic study.
- The Helsinki Heart Study: Basic design and randomization procedure
- Prevention of the Angiographic Progression of Coronary and Vein-Graft Atherosclerosis by Gemfibrozil After Coronary Bypass Surgery in Men With Low Levels of HDL Cholesterol
- Serum Lipids in Angiographically Assessed Coronary Atherosclerosis
- Progression of coronary artery disease in randomized medical and surgical patients over a 5-year angiographic follow-up
- Effects of physical training on circulation at rest and during exercise∗
- Hemodynamic Consequences of Physical Training after Myocardial Infarction
- SERUM PRE‐β‐1 LIPOPROTEIN FRACTION IN CORONARY ATHEROSCLEROSIS
- Lp(a) Lipoprotein/pre‐β1‐lipoprotein, serum lipids and atherosclerotic disease
- Helsinki Heart Study
- Hemodynamic Effects of Nitroglycerin in Patients with Angina Pectoris Studied by an Atrial Pacing Method
- Efficacy of Gemfibrozil in Dyslipidaemic Subjects with Suspected Heart Disease. An Ancillary Study in the Helsinki Heart Study Frame Population
- Further studies of Lp(a) lipoprotein/pre‐β1,‐lipoprotein in patients with coronary heart disease
- Genetic variation in serum low density lipoproteins and lipid levels in man.